Release Date: 20/11/19 18:30 Summary: Change of Director's Interest Notices Price Sensitive: No Download Document 380.73KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%